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Background: Globicatella are streptococcus-like organisms that have been rarely isolated from clinical
specimens. Their epidemiology and clinical significance remain largely unknown.
Aims: To describe two cases of Globicatella bacteraemia identified by 16S ribosomal RNA (rRNA) gene
sequencing.
Methods: Two unidentified streptococcus-like bacteria isolated from blood cultures of patients were subject
to 16S rRNA gene sequencing.
Results: Two cases of Globicatella bacteraemia were identified by 16S rRNA gene sequencing. In the first
case, a gram positive coccus was isolated from the blood culture of an 80 year old woman with diabetes
mellitus and nosocomial sepsis, who died the day after developing the bacteraemia. The bacterium was
unidentified by conventional phenotypic tests, the Vitek (gram positive identification) and the ATB
expression (ID32 Strep) systems. In the second case, a similar bacterium was isolated from the blood
culture of a 92 year old woman with polymicrobial acute pyelonephritis complicated by septic shock, who
subsequently recovered after antibiotic treatment. 16S rRNA gene sequencing of the two isolates showed
0.5% nucleotide difference from that of G. sulfidifaciens and 0.7% nucleotide difference from that of
G. sanguinis, indicating that they were Globicatella species.
Conclusions: Because Globicatella is rarely encountered in clinical microbiology laboratories, it may have
been overlooked or misidentified in these cases. 16S rRNA gene sequencing is a useful tool to better
characterise the epidemiology and clinical significance of Globicatella.
S
ince the recognition of the 16S ribosomal RNA (rRNA)
gene as a new standard for classification and identifica-
tion of bacteria,1 2 most bacterial species have been
subjected to 16S rRNA gene sequence analysis, with
reclassification made and new species identified. The
taxonomy of the genera Streptococcus, Enterococcus,
Lactococcus, and related members have also undergone major
revisions.3–5 Recently, we reported the use of this technique
for identifying and defining the clinical significance of
streptococci6–11 and streptococcus-like organisms;12–14 and
discovery of a novel Streptococcus species.15 16
The genus Globicatella was first described in 1992 when
several unidentified streptococcus-like clinical isolates were
characterised in the USA.17 The isolates were isolated from
blood cultures of patients with bacteraemia, urine of patients
with urinary tract infections, and cerebrospinal fluid of a
patient with meningitis, but the clinical details were not
described. Based on their unique phenotypic characteristics
and phylogenetic position by 16S rRNA gene sequence
analysis, they were classified in a new genus Globicatella,
as G. sanguis, which was later renamed as G. sanguinis.
G. sanguinis was also later isolated from a lamb with
meningoencephalitis in Spain.18 Subsequently, a new species
of the genus, G. sulfidifaciens, was described, when several
animal isolates from Belgium with resemblance to G.
sanguinis were studied. They comprised isolates from the
lungs of calves and a lamb with purulent lung infections, and
joint fluid of a pig and a calf with polyarthritis.19 Although
there was 99.2% similarity in their 16S rRNA gene sequences
to those of G. sanguinis, they were classified as a new species
based on differences in their whole cell protein patterns and
biochemical profiles. Since then, there have been no further
reports on the isolation of Globicatella from humans and the
clinical significance of this rarely encountered genus remains
to be determined. In this report, we describe the application
of 16S ribosomal RNA gene sequencing in characterising two
cases of Globicatella bacteraemia. The difficulties in identify-
ing the two isolates in clinical microbiology laboratories and
their clinical significance are also discussed.
METHODS
Microbiological methods
Clinical specimens were collected and handled according to
standard protocols. The BACTEC 9240 blood culture system
(Becton Dickinson, MD, USA) was used. All isolates were
identified by standard conventional biochemical methods,20
the Vitek System (gram positive identification; GPI)
(bioMerieux Vitek, Hazelwood, M), USA) and the ATB
expression system (ID32 Strep) (bioMerieux Vitek).
Antimicrobial susceptibility was tested by disk diffusion
and E-test (AB Biodisk, Solna, Sweden) and results inter-
preted according to the NCCLS criteria for anaerobic
bacteria.21 All tests were performed in triplicate with freshly
prepared media on separate occasions.
Extraction of bacterial DNA for 16S ribosomal RNA
gene sequencing
Bacterial DNA extraction was performed as described
previously.6 15 Briefly, 80 ml of NaOH (0.05 mol/l) was added
to 20 ml of bacterial cells suspended in distilled water and the
mixture was incubated at 60 C˚ for 45 minutes, followed by
addition of 6 ml of Tris-HCl (pH 7.0), achieving a final pH of
8.0. The resultant mixture was diluted 1006, and 5 ml of the
diluted extract was used for PCR.
Abbreviations: GPI, gram positive identification; rRNA, ribosomal RNA
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PCR, gel electrophoresis, and 16S ribosomal RNA
gene sequencing
PCR amplification and DNA sequencing of the 16S rRNA
gene was performed according to our previous publica-
tions.6 12 Briefly, DNase I treated distilled water and PCR
master mix (dNTPs, PCR buffer, and Taq polymerase) were
used in all PCR reactions by adding 1 U of DNase I
(Pharmacia, Sweden) to 40 ml of distilled water or PCR
master mix, incubating the mixture at 25 C˚ for 15 minutes,
and subsequently at 95 C˚ for 10 minutes to inactivate the
DNase I. The bacterial DNA extract and control were
amplified with 0.5 mmol/l primers (LPW57 59-
AGTTTGATCCTGGCTCAG-39 and LPW205 59-
CTTGTTACGACTTCACCC-39; Gibco BRL, Rockville, MD,
USA). The PCR mixture (50 ml) contained bacterial DNA,
PCR buffer (10 mmol/l Tris-HCl pH 8.3, 50 mmol/l KCl,
2 mmol/l MgCl2, and 0.01% gelatin), 200 mmol/l of each
dNTP and 1.0 U Taq polymerase (Boehringer Mannheim,
Germany). The mixtures were amplified in in an automated
thermal cycler (Perkin-Elmer Cetus, Gouda, The
Netherlands), using 40 cycles of 94 C˚ for 1 minute, 60 C˚ for
1 minute, and 72 C˚ for 2 minutes, with a final extension at
72 C˚ for 10 minutes. DNase I treated distilled water was used
as the negative control. A 10 ml sample of each amplified
product was electrophoresed in 1.5% (w/v) agarose gel, with a
molecular size marker (wX174 HaeIII digest,; Boehringer
Mannheim, Germany) in parallel. Electrophoresis in Tris
borate EDTA buffer was performed at 100 V for 1.5 hours.
The gel was stained with ethidium bromide (0.5 mg/ml) for
15 minutes, rinsed, and photographed under 312 nm ultra-
violet light illumination.
The PCR products were gel purified using the QIAquick
PCR purification kit (QIAgen, Hilden, Germany). Both
strands of the PCR product were sequenced twice with an
ABI 377 automated sequencer according to manufacturers’
instructions (Perkin-Elmer, Foster City, CA, USA), using the
PCR primers. The sequences of the PCR products were
compared with known 16S rRNA gene sequences in GenBank
(hwww.ncbi.nlm.nih.gov) by multiple sequence alignment
using the Clustal W program.22 Phylogenetic tree construction
was performed using Clustal X (version 1.81) 23 and the
neighbour joining method with GrowTree (Genetics
Computer Group Inc., San Diego, USA). In total, 1360
nucleotide positions were included in the analysis.
RESULTS
Patients and identification of the bacterial strains by
conventional methods and commercially available
systems
Patient 1
An 80 year old Chinese woman was admitted to hospital
because of a 3 month history of chronic diarrhoea. She had
been passing loose stool with mucus 2–3 times a day. She had
diabetes mellitis, hypertension, and gouty arthritis, and was
receiving oral hypoglycaemic and anti-hypertensive medica-
tions. On admission, she was afebrile. Abdominal examina-
tion and colonoscopy was unremarkable. She was found to
have hypercalcaemia with adjusted serum calcium
3.14 mmol/l and was given intravenous fluid replacement,
loop diuretics, and bisphosphonate with gradual normal-
isation of serum calcium. She developed sudden cardiac
arrest 2 weeks after admission and was stabilised after initial
resuscitation. Her total leukocyte count was 226109/l,
haemoglobin level 9.8 g/dl, and platelet count 4576109/l.
Her serum urea was 19.3 mmol/l, creatinine 211 mmol/l,
albumin 30 g/l, globulin 36 g/l, bilirubin 7 mmol/l, alkaline
phosphatase 115 IU/l, and alanine aminotransferase 87 IU/l.
Blood cultures were performed. However, she continued to
deteriorate and succumbed on the next day.
On day 2 post-incubation, the aerobic blood culture bottle
showed a gram positive coccus (isolate 1). It grew on sheep
blood agar as greyish white, a-haemolytic colonies of 0.5 mm
in diameter after 24 hours of incubation at 37 C˚ in ambient
air. There was enhancement of growth in 5% CO2 and
anaerobic environment. It also grew on MacConkey agar but
did not grow in 6.5% NaCl. It was positive for pyrolidonyl
arylamidase and esculin, and negative for catalase, arginine,
or hippurate hydrolysis, bile aesculin, and Voges-Proskauer
tests. It was non-groupable with Lancefield groups A, B, C, D,
F, or G antisera. Both the Vitek and ATB expression systems
showed that it was ‘‘unidentified’’ (table 1). It was
susceptible to vancomycin (MIC 0.25 mg/ml), intermediately
susceptible to penicillin (MIC 2 mg/ml), and resistant to and
cefotaxime (MIC 4 mg/ml), erythromycin, clindamycin, and
neomycin.
Patient 2
A 92-year-old Chinese woman was admitted to hospital
because of fever and productive cough with yellow sputum
for one day. She had dementia, congestive heart failure, and
history of recurrent urinary tract infection. She was bed-
ridden and was put on nasogastric tube feeding. On
admission, her oral temperature was 39.5 C˚. Physical
examination did not reveal an obvious focus of infection.
Her total leukocyte count was 36.36109/l, haemoglobin level
11.1 g/dl, and platelet count 956109/l. Her renal and liver
function tests were within normal limits. Blood cultures were
performed. She went into septic shock soon after admission
and empirical intravenous cefuroxime was administered.
Urine microscopy showed the presence of numerous leuco-
cytes and bacteria. Urine culture recovered Pseudomonas
aeruginosa with bacterial count .100 000 cfu/ml.
Ultrasonography of the kidneys only showed the presence
of a renal stone on the right side with no evidence of
obstructive uropathy. Antibiotic was switched to intravenous
ceftazidime. Her fever responded and she was discharged
after 2 weeks of antibiotics.
On day 2 post-incubation, the aerobic blood culture bottle
turned positive with a gram negative bacillus and two gram
positive cocci. The gram negative bacillus and one of the gram
positive cocci were identified as Pseudomonas aeruginosa and
Streptococcus sanguis respectively. The other gram positive
coccus (isolate 2) possessed phenotypic characteristics similar
to isolate 1 (table 1). It was susceptible to vancomycin (MIC
0.25 mg/ml) and clindamycin, intermediately susceptible to
penicillin (MIC 1 mg/ml) and cefotaxime (MIC 2 mg/ml), and
resistant to erythromycin and neomycin.
16S ribosomal RNA gene sequencing and
phylogenetic analysis
PCR of the 16S rRNA gene of both isolates showed bands at
about 1450 bp. The 16S rRNA gene sequences of the two
isolates were identical and had 0.5% nucleotide difference
from G. sulfidifaciens (GenBank accession no. AJ297627), 0.7%
nucleotide difference from G. sanguinis (GenBank accession
no. S50214), 3.69% nucleotide difference from Facklamia
hominis (GenBank accession no. Y10772), 4.9% difference
from Aerosphaera taetra (GenBank accession no. AJ279038),
and 5.5% difference from F. languida (GenBank accession no.
Y18053), indicating that the two isolates belong to the genus
Globicatella (fig 1).
Based on their phenotypic and genotypic data, the two
isolates could not be assigned to a particular species of the
genus Globicatella. Phenotypically, they resembled G. sanguinis
in the production of pyrrolidonylarylamidase and the
negative H2S and b-glucuronidase production. On the other
hand, they resembled G. sulfidifaciens in that they did not use
mannitol and did not produce N-acetyl-b-glucosaminidase.
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However, like G. sanguinis, isolate 1 used ribose, while isolate
2. like G. sulfidifaciens, did not (table 1). Genotypically, the
16S rRNA gene sequences of the two isolates were close to
both G. sulfidifaciens and G. sanguinis, which possess highly
homologous 16S rRNA sequences with only 0.8% difference.
Therefore, the identification of more strains of Globicatella and
correlation of their phenotypic characteristics with 16S rRNA
gene sequences should help in defining the number of
different species within the genus.
DISCUSSION
We describe two cases of Globicatella bacteraemia charac-
terised by 16S rRNA gene sequencing. The two isolates were
unidentified by conventional biochemical tests and commer-
cial identification systems, and were only confirmed to be
Globicatella species after 16S rRNA gene sequencing. In
retrospect, the phenotypic characteristics of the two blood
culture isolates actually closely resembled those of Globicatella
(table 1). They are facultative anaerobic, catalase negative, a-
haemolytic, gram positive cocci. Similar to G. sanguinis and G.
sulfidifaciens, arginine is not hydrolysed, urease not produced,
and Voges-Proskauer test negative for the two isolates. While
both G. sanguinis and G. sulfidifaciens grow in 6.5% NaCl, one
of our isolates did not. Identification of more isolates of
Globicatella would help delineate the phenotypic character-
istics and variations within the genus. As Globicatella is rarely
encountered in clinical laboratories, most technicians and
microbiologists are not familiar with their phenotypic
characteristics and identification. As a result, the bacterium
may be overlooked when isolated or reported as unidentified
streptococcus-like organisms. 16S rRNA gene sequencing will
continue to be useful in the characterisation of rarely
encountered bacteria and defining their clinical signifi-
cance.6 13 24 As PCR and sequencing techniques are becoming
Table 1 Phenotypic characteristics of the two blood culture isolates, Globicatella
sulfidifaciens, and Globicatella sanguinis
Characteristics Isolate 1 Isolate 2
G.
sulfidaciens19
G.
sanguinis17 19
Catalase 2 2 2 2
Lancefield grouping Non-group A,
B, C, D, F, or G
Non-group A,
B, C, D, F, or G
Resistance to bacitracin 2 2
Resistance to optochin 2 2
Growth in 6.5% NaCl 2 + + +
Growth in 10% bile 2 +
Growth in 40% bile 2 2
Esculin hydrolysis + 2 + +
Hippurate hydrolysis 2 2 2 +
Arginine hydrolysis 2 2 2 2
Urease 2 2 2 2
Voges2Proskauer test 2 2 2 2
Tetrazolium reduction 2 2 2
Resistance to novobiocin 2 2
Production of H2S 2 2 + 2
Utilisation of:
Hemicellulase 2 2
Dextrose + + +
Lactose 2 2 2 V
Mannitol 2 2 2 +
Raffinose 2 + + +
Salicin + + +
Sorbitol 2 2 2 V
Sucrose + + + +
Trehalose + + + +
Arabinose 2 2 2
Pyruvate 2 2 2
Pullulan 2 + V
Inulin 2 + + 2
Melibiose 2 + + +
Melezitose 2 2 2
Cellobiose + + +
Ribose + 2 2 +
Xylose 2 2 2
Maltose + + + +
Glycogen 2 + + +
D-Arabitol 2 2
Methyl-B-D-glucopyranoside + +
Tagatose 2 2
Cyclodextrin 2 2
Pyrrolidonylarylamidase + + 2 +
a-galactosidase + + + +
b-glucuronidase 2 2 + 2
b-galactosidase + + V +
b-glucosidase + 2
Alanine-phenylalanine-proline
arylamidase
+ + +
N-acetyl-b-glucosaminidase 2 2 2 +
Glycyl-tryptophane arylamidase 2 2
b-mannosidase + 2
Alkaline phosphatase 2 2 2
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more readily available in clinical laboratories, this molecular
tool is probably the most practical approach to identify these
bacteria.
The clinical significance of the two isolates in our two
patients is evident by their isolation from blood in association
with the development of fever and neutrophilia. Their
infections have been severe because the first patient died
soon after the bacteraemia and the second was complicated
by septic shock. While the source of the bacteraemia in the
first patient could not be identified, the second case probably
represents a case of polymicrobial acute pyleonephritis
complicated by bacteraemia. S. sanguis and P. aeruginosa,
which were concomitantly isolated from the blood of the
second patient, are known pathogens of the urinary tract and
can reside in the gastrointestinal tract.25 Moreover, G. sanguis
has been isolated from the urine of patients with urinary tract
infections.17 Therefore, Globicatella is likely to be an uncom-
mon cause of urinary tract infections and may have
originated from the gut. However, only P. aeruginosa was
recovered in her urine. This may be explained by the slower
growth of Globicatella and S. sanguis as opposed to the larger
colonies of P. aeruginosa. Nevertheless, as the second patient
had mixed infections, the role of Globicatella in this case still
remains to be determined. Further studies are required to
investigate the role of Globicatella in human infections.
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TAKE HOME MESSAGES
N Globicatella are streptococcus-like organisms that have
been rarely isolated from clinical specimens, whose
epidemiology and clinical significance remain largely
unknown.
N Using 16S rRNA sequencing, two cases were identified
as Globicatella spp.
N The infections were severe, leading to death in one
case and septic shock in the other.
N Further studies are required to investigate the role of
Globicatella in human infections.
306 Lau, Woo, Li, et al
www.jclinpath.com
 on 1 March 2007 jcp.bmj.comDownloaded from 
11 Lee RA, Woo PC, To AP, et al. Geographical difference of disease association
in Streptococcus bovis bacteraemia. J Med Microbiol 2003;52:903–8.
12 Woo PC, Tam DM, Lau SK, et al. Enterococcus cecorum empyema thoracis
successfully treated with cefotaxime. J Clin Microbiol 2004;42:919–22.
13 Woo PC, Lau SK, Fung AM, et al. Gemella bacteraemia characterised by 16S
ribosomal RNA gene sequencing. J Clin Pathol 2003;56:690–3.
14 Woo PC, Fung AM, Lau SK, et al. Granulicatella adiacens and Abiotrophia
defectiva bacteraemia characterized by 16S rRNA gene sequencing. J Med
Microbiol 2003;52:137–40.
15 Woo PCY, Tam DMW, Leung KW, et al. Streptococcus sinensis sp. nov., a
novel Streptococcus species isolated from a patient with infective endocarditis.
J Clin Microbiol 2002;40:805–10.
16 Woo PC, Teng JL, Leung KW, et al. Streptococcus sinensis may react with
Lancefield group F antiserum. J Med Microbiol 2004;53:1083–8.
17 Collins MD, Aguirre M, Facklam RR, et al. Globicatella sanguis gen. nov., sp.
nov., a new gram-positive catalase-negative bacterium from human sources.
J Appl Bacteriol 1992;73:433–7.
18 Vela AI, Fernandez E, las Heras A, et al. Meningoencephalitis associated with
Globicatella sanguinis infection in lambs. J Clin Microbiol 2000;38:4254–5.
19 Vandamme P, Hommez J, Snauwaert C, et al. Globicatella sulfidifaciens sp.
nov., isolated from purulent infections in domestic animals. Int J Syst Evol
Microbiol 2001;51:1745–9.
20 Murray PR, Baro EJ, Jorgensen JH, et al. Manual of clinical microbiology, 8th
ed. Washington DC: American Society for Microbiology, 2003.
21 National Committee for Clinical Laboratory Standards. M2-A7, performance
standards for antimicrobial disk susceptibility tests. Approved standard, 8th
ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003.
22 Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity
of progressive multiple sequence alignment through sequence weighting,
position-specific gap penalties and weight matrix choice. Nucleic Acids Res
1994;22:4673–80.
23 Jeanmougin F, Thompson JD, Gouy M, et al. Multiple sequence alignment
with ClustalX. Trends Biochem Sci 1998;10:403–5.
24 Lau SK, Woo PC, Teng JL, et al. Identification by 16S ribosomal RNA gene
sequencing of Arcobacter butzleri bacteraemia in a patient with acute
gangrenous appendicitis. Mol Pathol 2002;55:182–5.
25 Christensen JJ, Korner B, Kjaergaard H. Aerococcus-like organism—an
unnoticed urinary tract pathogen. APMIS 1989;97:539–46.
11th European Forum on Quality Improvement in Health Care
26–28 April 2006, Prague, Czech Republic
For further information please go to: www.quality.bmjpg.com
Book early to benefit from a discounted delegate rate
Globicatella bacteraemia 307
www.jclinpath.com
 on 1 March 2007 jcp.bmj.comDownloaded from 
